# Johnson & Johnson (JNJ) FY2026 Q2 P&L / Income Statement

- Company: Johnson & Johnson (JNJ)
- Period: 2026-03-30 to 2026-06-28
- Filing: Q2 FY2026 10-Q, filed 2026-07-23, accession number 0000200406-26-000153
- Page: https://plicit.ai/financials/jnj/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/jnj-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Geography

Income statement for 2026-03-30 through 2026-06-28. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 25,310,000,000 US dollars
- **Cost of products sold**: 8,051,000,000 US dollars
- **Gross profit**: 17,259,000,000 US dollars
- **Operating expenses (calculated)**: 10,119,000,000 US dollars
- **Operating profit (calculated)**: 7,140,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 393,000,000 US dollars
- **Earnings before provision for taxes on income**: 6,747,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 1,213,000,000 US dollars
- **Net earnings**: 5,534,000,000 US dollars
- **Innovative Medicine - UNITED STATES**: 9,979,000,000 US dollars
- **Innovative Medicine - International**: 6,405,000,000 US dollars
- **MedTech - UNITED STATES**: 4,554,000,000 US dollars
- **MedTech - International**: 4,372,000,000 US dollars
- **Research and development expense**: 3,653,000,000 US dollars
- **Restructuring (Note 12)**: 34,000,000 US dollars
- **Selling, marketing and administrative expenses**: 6,432,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography (4 categories)

- Page: https://plicit.ai/financials/jnj/fy2026-q2-income-statement/revenue-by-geography-4-categories
- Chart image: https://plicit.ai/charts/jnj-fy2026-q2-revenue-by-geography-4-categories-sankey.png

Income statement for 2026-03-30 through 2026-06-28. View: Geography (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 25,310,000,000 US dollars
- **Cost of products sold**: 8,051,000,000 US dollars
- **Gross profit**: 17,259,000,000 US dollars
- **Operating expenses (calculated)**: 10,119,000,000 US dollars
- **Operating profit (calculated)**: 7,140,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 393,000,000 US dollars
- **Earnings before provision for taxes on income**: 6,747,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 1,213,000,000 US dollars
- **Net earnings**: 5,534,000,000 US dollars
- **UNITED STATES**: 14,533,000,000 US dollars
- **Europe**: 5,726,000,000 US dollars
- **Western Hemisphere, excluding U.S.**: 1,309,000,000 US dollars
- **Asia-Pacific, Africa**: 3,742,000,000 US dollars
- **Research and development expense**: 3,653,000,000 US dollars
- **Restructuring (Note 12)**: 34,000,000 US dollars
- **Selling, marketing and administrative expenses**: 6,432,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/jnj/fy2026-q2-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/jnj-fy2026-q2-revenue-by-business-segment-sankey.png

Income statement for 2026-03-30 through 2026-06-28. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 25,310,000,000 US dollars
- **Cost of products sold**: 8,051,000,000 US dollars
- **Gross profit**: 17,259,000,000 US dollars
- **Operating expenses (calculated)**: 10,119,000,000 US dollars
- **Operating profit (calculated)**: 7,140,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 393,000,000 US dollars
- **Earnings before provision for taxes on income**: 6,747,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 1,213,000,000 US dollars
- **Net earnings**: 5,534,000,000 US dollars
- **Innovative Medicine**: 16,384,000,000 US dollars
- **MedTech**: 8,926,000,000 US dollars
- **Research and development expense**: 3,653,000,000 US dollars
- **Restructuring (Note 12)**: 34,000,000 US dollars
- **Selling, marketing and administrative expenses**: 6,432,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography (2 categories)

- Page: https://plicit.ai/financials/jnj/fy2026-q2-income-statement/revenue-by-geography-2-categories
- Chart image: https://plicit.ai/charts/jnj-fy2026-q2-revenue-by-geography-2-categories-sankey.png

Income statement for 2026-03-30 through 2026-06-28. View: Geography (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 25,310,000,000 US dollars
- **Cost of products sold**: 8,051,000,000 US dollars
- **Gross profit**: 17,259,000,000 US dollars
- **Operating expenses (calculated)**: 10,119,000,000 US dollars
- **Operating profit (calculated)**: 7,140,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 393,000,000 US dollars
- **Earnings before provision for taxes on income**: 6,747,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 1,213,000,000 US dollars
- **Net earnings**: 5,534,000,000 US dollars
- **UNITED STATES**: 14,533,000,000 US dollars
- **International**: 10,777,000,000 US dollars
- **Research and development expense**: 3,653,000,000 US dollars
- **Restructuring (Note 12)**: 34,000,000 US dollars
- **Selling, marketing and administrative expenses**: 6,432,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.